IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i20p13076-d939398.html
   My bibliography  Save this article

Gut Microbiome: The Interplay of an “Invisible Organ” with Herbal Medicine and Its Derived Compounds in Chronic Metabolic Disorders

Author

Listed:
  • Dong-Woo Lim

    (Department of Diagnostics, College of Korean Medicine, Dongguk University, Dongguk-Ro 32, Goyang 10326, Korea)

  • Jing-Hua Wang

    (Institute of Bioscience & Integrative Medicine, Daejeon University, 75, Daedeok-daero 176, Seo-gu, Daejeon 35235, Korea)

Abstract

Resembling a concealed “organ” in a holobiont, trillions of gut microbes play complex roles in the maintenance of homeostasis, including participating in drug metabolism. The conventional opinion is that most of any drug is metabolized by the host and that individual differences are principally due to host genetic factors. However, current evidence indicates that only about 60% of the individual differences in drug metabolism are attributable to host genetics. Although most common chemical drugs regulate the gut microbiota, the gut microbiota is also known to be involved in drug metabolism, like the host. Interestingly, many traditional herbal medicines and derived compounds are biotransformed by gut microbiota, manipulating the compounds’ effects. Accordingly, the gut microbiota and its specified metabolic pathways can be deemed a promising target for promoting drug efficacy and safety. However, the evidence regarding causality and the corresponding mechanisms concerning gut microbiota and drug metabolism remains insufficient, especially regarding drugs used to treat metabolic disorders. Therefore, the present review aims to comprehensively summarize the bidirectional roles of gut microbiota in the effects of herbal medicine in metabolic diseases to provide vital clues for guiding the clinical application of precision medicine and personalized drug development.

Suggested Citation

  • Dong-Woo Lim & Jing-Hua Wang, 2022. "Gut Microbiome: The Interplay of an “Invisible Organ” with Herbal Medicine and Its Derived Compounds in Chronic Metabolic Disorders," IJERPH, MDPI, vol. 19(20), pages 1-16, October.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:20:p:13076-:d:939398
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/20/13076/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/20/13076/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Michael Zimmermann & Maria Zimmermann-Kogadeeva & Rebekka Wegmann & Andrew L. Goodman, 2019. "Mapping human microbiome drug metabolism by gut bacteria and their genes," Nature, Nature, vol. 570(7762), pages 462-467, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Pierre H. H. Schneeberger & Morgan Gueuning & Sophie Welsche & Eveline Hürlimann & Julian Dommann & Cécile Häberli & Jürg E. Frey & Somphou Sayasone & Jennifer Keiser, 2022. "Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    2. Yadid M. Algavi & Elhanan Borenstein, 2023. "A data-driven approach for predicting the impact of drugs on the human microbiome," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    3. Tao Li & Zhi-Jing Xu & Shu-Ting Zhang & Jia Xu & Piaopiao Pan & Ning-Yi Zhou, 2024. "Discovery of a Ni2+-dependent heterohexameric metformin hydrolase," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    4. Wen-Long Sun & Sha Hua & Xin-Yu Li & Liang Shen & Hao Wu & Hong-Fang Ji, 2023. "Microbially produced vitamin B12 contributes to the lipid-lowering effect of silymarin," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    5. Francesca De Filippis & Vincenzo Valentino & Giuseppina Sequino & Giorgia Borriello & Marita Georgia Riccardi & Biancamaria Pierri & Pellegrino Cerino & Antonio Pizzolante & Edoardo Pasolli & Mauro Es, 2024. "Exposure to environmental pollutants selects for xenobiotic-degrading functions in the human gut microbiome," Nature Communications, Nature, vol. 15(1), pages 1-11, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:20:p:13076-:d:939398. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.